According to a new research report by RNCOS entitled, “Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) – World Forecasts to 2022”, the global microfluidics industry is witnessing an impressive growth owing to the increasing cancer and other lifestyle disease incidences, chip miniaturization, and rising investments in this market. The industry is anticipated to a double digit growth in next five years. Other significant advantages of microfluidics technology includes less reagent consumption and improved accuracy of the reaction assays, thereby penetrating various other branches of medicinal biology such as diagnostics, drug development, and pharmaceutical & genomics research. The microfluidics technology has wide applications in the field of in-vitro diagnostics. The microfluidics billion dollar market is likely to be driven by one of the most important factor i.e. reduced cost of drug development procedures. The market is majorly influenced by diagnostic companies for example, Roche, Illumina, PerkinElmer, Agilent Technologies, Shimadzu, etc., amongst others which are increasingly investing in this market through various acquisitions and agreements.


Research Analysis and Highlights
The report is spread in 80 pages and provides an in-depth research and rational analysis of the current status and future prospect of the Global Microfluidics Industry. The report provides a clear picture of the technology, factors driving the industry growth, and challenges faced by the industry. In addition to this, the study includes mergers & acquisition deals that have occurred during past two years. The report further highlights market segmentation of the industry by material, components, applications, and geography. With special emphasis on competitive landscape and dominant players in the market, the research provides valuable information to the investors who are looking to enter in this market.

Some of the key highlights of the report include the following:

• Increasing Demand of POC diagnostics
• In-Vitro Diagnostics application leading the Global Microfluidics Market
• Miniaturization of Chip aiding the growth of Microfluidics industry

Some of our Related Reports are:

• Global Point of Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM903.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm


ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.